Novartis AG (NVS) NYSE
147.97
-3.02(-2.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 267.32B |
| Enterprise Value | 292.92B |
| P/E Ratio | 20.24 |
| PEG Ratio | -9.91 |
| Price/Sales Ratio | 5.03 |
| Price/Book Ratio | 6.15 |
| Enterprise/Revenue | 5.49 |
| Enterprise/EBITDA | 13.55 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.25 |
| Operating Margin | 0.31 |
Management Effectiveness
| Return On Assets | 0.12 |
| Return On Equity | 0.33 |
Income Statement
| Revenue | 54.81B |
| Revenue/Share | 29.41 |
| Gross Profit | 41.12B |
| EBITDA | 22.99B |
| Net Income | 14.06B |
| Diluted EPS | 7.19 |
Balance Sheet
| Total Cash | 11.59B |
| Total Cash/Share | 6.05 |
| Total Debt | 37.11B |
| Total Debt/Equity | 0.8 |
| Current Ratio | 1.12 |
| Book Value Per Share | 24.32 |
Price History
| 52-Week Change | 32.82 |
| 52-Week High | 170.46 |
| 52-Week Low | 104.93 |
| Moving Average 50 Days | 156.7 |
| Moving Average 200 Days | 136.55 |
Statistics
| Average Volume | 2.3M |
| Shares Outstanding | 1.93B |
| % Held by Institutions | 7.21 |
Dividend And Splits
| Trailing Annual Dividend Rate | 4.73 |
| Trailing Annual Dividend Yield | 3.19 |
| Payout Ratio | 0.54 |
| Last Split Factor | 279:250 |
| Last Split Date | April 09, 2019 |
